001     247521
005     20240826165949.0
024 7 _ |a 10.1016/j.neurobiolaging.2022.12.005
|2 doi
024 7 _ |a pmid:36706574
|2 pmid
024 7 _ |a 0197-4580
|2 ISSN
024 7 _ |a 1558-1497
|2 ISSN
024 7 _ |a altmetric:140934974
|2 altmetric
037 _ _ |a DZNE-2023-00198
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Ballarini, Tommaso
|0 P:(DE-2719)9000476
|b 0
|e First author
|u dzne
245 _ _ |a Linking early-life bilingualism and cognitive advantage in older adulthood.
260 _ _ |a Amsterdam [u.a.]
|c 2023
|b Elsevier Science
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1709556097_22643
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Previous studies have identified bilingualism as a protective factor against dementia. Here we aimed to test whether being bilingual at different life stages impacts cognition and brain structure in older adulthood. We included 746 participants from the DZNE-Longitudinal Cognitive Impairment and Dementia Study (DELCODE). Assessment of bilingualism at 3 life stages (early: 13-30, middle: 30-65 and late: over 65 years old) was determined with the Lifetime of Experiences Questionnaire. Individuals reporting bilingualism (i.e., daily use of L2) in the early life stage outperformed monolinguals on learning & memory, working-memory, executive functions and language. Bilingualism in middle life stage showed a significant advantage on learning & memory, while no effect of bilingualism in old life stage was identified. Brain gray matter volume was not associated with L2 use and did not differ between groups. However, stronger correlations between brain gray matter volume in selected brain regions and cognitive performance were found in bilingual participants in the early and middle life stages. Our results indicate that bilingualism in early life might provide a long-lasting protective effect on cognition and shape the brain to sustain cognitive performance in older adulthood.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
536 _ _ |a 352 - Disease Mechanisms (POF4-352)
|0 G:(DE-HGF)POF4-352
|c POF4-352
|f POF IV
|x 1
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Aging
|2 Other
650 _ 7 |a Bilingualism
|2 Other
650 _ 7 |a Brain structure
|2 Other
650 _ 7 |a Neuropsychology
|2 Other
650 _ 7 |a Voxel-based-morphometry
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Multilingualism
|2 MeSH
650 _ 2 |a Cognition
|2 MeSH
650 _ 2 |a Executive Function
|2 MeSH
650 _ 2 |a Brain
|2 MeSH
650 _ 2 |a Dementia
|2 MeSH
693 _ _ |0 EXP:(DE-2719)DELCODE-20140101
|5 EXP:(DE-2719)DELCODE-20140101
|e Longitudinal Cognitive Impairment and Dementia Study
|x 0
700 1 _ |a Kuhn, Elizabeth
|0 P:(DE-2719)9002169
|b 1
|u dzne
700 1 _ |a Röske, Sandra
|0 P:(DE-2719)2810395
|b 2
|u dzne
700 1 _ |a Altenstein, Slawek
|0 P:(DE-2719)2811720
|b 3
|u dzne
700 1 _ |a Bartels, Claudia
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Buchholz, Friederike
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Buerger, Katharina
|0 P:(DE-2719)2811351
|b 6
|u dzne
700 1 _ |a Dechent, Peter
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Dobisch, Laura
|0 P:(DE-2719)2811611
|b 8
|u dzne
700 1 _ |a Ewers, Michael
|0 P:(DE-2719)9000543
|b 9
|u dzne
700 1 _ |a Fliessbach, Klaus
|0 P:(DE-2719)2811326
|b 10
|u dzne
700 1 _ |a Freiesleben, Silka Dawn
|0 P:(DE-2719)2812392
|b 11
|u dzne
700 1 _ |a Frommann, Ingo
|0 P:(DE-2719)2810481
|b 12
|u dzne
700 1 _ |a Gabelin, Tatjana
|0 P:(DE-2719)9000554
|b 13
|u dzne
700 1 _ |a Glanz, Wenzel
|0 P:(DE-2719)2811614
|b 14
|u dzne
700 1 _ |a Görß, Doreen
|0 P:(DE-2719)2812583
|b 15
|u dzne
700 1 _ |a Haynes, John Dylan
|0 P:(DE-HGF)0
|b 16
700 1 _ |a Incesoy, Enise I
|0 P:(DE-2719)9001517
|b 17
|u dzne
700 1 _ |a Janowitz, Daniel
|0 P:(DE-2719)9002557
|b 18
|u dzne
700 1 _ |a Kilimann, Ingo
|0 P:(DE-2719)2810394
|b 19
|u dzne
700 1 _ |a Kleineidam, Luca
|0 P:(DE-2719)2812139
|b 20
|u dzne
700 1 _ |a Kobeleva, Xenia
|0 P:(DE-2719)9001475
|b 21
|u dzne
700 1 _ |a Laske, Christoph
|0 P:(DE-2719)2000055
|b 22
|u dzne
700 1 _ |a Lohse, Andrea
|0 P:(DE-2719)2811189
|b 23
|u dzne
700 1 _ |a Maier, Franziska
|0 P:(DE-HGF)0
|b 24
700 1 _ |a Munk, Matthias H
|0 P:(DE-2719)9001516
|b 25
|u dzne
700 1 _ |a Perneczky, Robert
|0 P:(DE-2719)2812234
|b 26
|u dzne
700 1 _ |a Peters, Oliver
|0 P:(DE-2719)2811024
|b 27
|u dzne
700 1 _ |a Priller, Josef
|0 P:(DE-2719)2811122
|b 28
|u dzne
700 1 _ |a Rauchmann, Boris Stephan
|0 P:(DE-2719)9001808
|b 29
|u dzne
700 1 _ |a Roy, Nina
|0 P:(DE-2719)2812341
|b 30
|u dzne
700 1 _ |a Scheffler, Klaus
|0 P:(DE-HGF)0
|b 31
700 1 _ |a Schneider, Anja
|0 P:(DE-2719)2812035
|b 32
|u dzne
700 1 _ |a Schott, Björn H
|0 P:(DE-2719)2814326
|b 33
|u dzne
700 1 _ |a Spottke, Annika
|0 P:(DE-2719)2811324
|b 34
|u dzne
700 1 _ |a Spruth, Eike Jakob
|0 P:(DE-2719)2812446
|b 35
|u dzne
700 1 _ |a Teipel, Stefan
|0 P:(DE-2719)2000026
|b 36
|u dzne
700 1 _ |a Wiltfang, Jens
|0 P:(DE-2719)2811317
|b 37
|u dzne
700 1 _ |a Wolfsgruber, Steffen
|0 P:(DE-2719)2810544
|b 38
|u dzne
700 1 _ |a Düzel, Emrah
|0 P:(DE-2719)2000005
|b 39
|u dzne
700 1 _ |a Jessen, Frank
|0 P:(DE-2719)2000032
|b 40
|u dzne
700 1 _ |a Wagner, Michael
|0 P:(DE-2719)2000057
|b 41
|e Last author
|u dzne
700 1 _ |a group, DELCODE study
|b 42
|e Collaboration Author
773 _ _ |a 10.1016/j.neurobiolaging.2022.12.005
|g Vol. 124, p. 18 - 28
|0 PERI:(DE-600)1498414-3
|p 18 - 28
|t Neurobiology of aging
|v 124
|y 2023
|x 0197-4580
856 4 _ |u https://www.sciencedirect.com/science/article/abs/pii/S0197458022002597
856 4 _ |u https://pub.dzne.de/record/247521/files/DZNE-2023-00198_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/247521/files/DZNE-2023-00198_Restricted.pdf?subformat=pdfa
|x pdfa
909 C O |p VDB
|o oai:pub.dzne.de:247521
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)9000476
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)9002169
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)2810395
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)2811720
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)2811351
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 8
|6 P:(DE-2719)2811611
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 9
|6 P:(DE-2719)9000543
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 10
|6 P:(DE-2719)2811326
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 11
|6 P:(DE-2719)2812392
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 12
|6 P:(DE-2719)2810481
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 13
|6 P:(DE-2719)9000554
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 14
|6 P:(DE-2719)2811614
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 15
|6 P:(DE-2719)2812583
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 17
|6 P:(DE-2719)9001517
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 18
|6 P:(DE-2719)9002557
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 19
|6 P:(DE-2719)2810394
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 20
|6 P:(DE-2719)2812139
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 21
|6 P:(DE-2719)9001475
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 22
|6 P:(DE-2719)2000055
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 23
|6 P:(DE-2719)2811189
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 25
|6 P:(DE-2719)9001516
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 26
|6 P:(DE-2719)2812234
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 27
|6 P:(DE-2719)2811024
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 28
|6 P:(DE-2719)2811122
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 29
|6 P:(DE-2719)9001808
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 30
|6 P:(DE-2719)2812341
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 32
|6 P:(DE-2719)2812035
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 33
|6 P:(DE-2719)2814326
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 34
|6 P:(DE-2719)2811324
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 35
|6 P:(DE-2719)2812446
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 36
|6 P:(DE-2719)2000026
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 37
|6 P:(DE-2719)2811317
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 38
|6 P:(DE-2719)2810544
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 39
|6 P:(DE-2719)2000005
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 40
|6 P:(DE-2719)2000032
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 41
|6 P:(DE-2719)2000057
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-352
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms
|x 1
914 1 _ |y 2023
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2022-11-10
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-10
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-08-24
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NEUROBIOL AGING : 2022
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-08-24
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-08-24
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2023-08-24
920 1 _ |0 I:(DE-2719)1011201
|k AG Wagner
|l Neuropsychology
|x 0
920 1 _ |0 I:(DE-2719)1811005
|k AG Endres
|l Interdisciplinary Dementia Research
|x 1
920 1 _ |0 I:(DE-2719)5000022
|k AG Dichgans
|l Vascular Cognitive Impairment & Post-Stroke Dementia
|x 2
920 1 _ |0 I:(DE-2719)1810002
|k AG Dirnagl
|l Vascular Pathology
|x 3
920 1 _ |0 I:(DE-2719)5000006
|k AG Düzel
|l Clinical Neurophysiology and Memory
|x 4
920 1 _ |0 I:(DE-2719)1110008
|k AG Simons
|l Molecular Neurobiology
|x 5
920 1 _ |0 I:(DE-2719)1011101
|k Patient Studies Bonn
|l Patient Studies Bonn
|x 6
920 1 _ |0 I:(DE-2719)1011102
|k AG Jessen
|l Clinical Alzheimer’s Disease Research
|x 7
920 1 _ |0 I:(DE-2719)1340013
|k KAP
|l Cooperation Unit for Applied Prevention Research (KAP)
|x 8
920 1 _ |0 I:(DE-2719)1510100
|k AG Teipel
|l Clinical Dementia Research (Rostock /Greifswald)
|x 9
920 1 _ |0 I:(DE-2719)1011001
|k AG Klockgether
|l Patient Studies
|x 10
920 1 _ |0 I:(DE-2719)1210000
|k AG Gasser
|l Parkinson Genetics
|x 11
920 1 _ |0 I:(DE-2719)5000007
|k AG Priller
|l Translational Neuropsychiatry
|x 12
920 1 _ |0 I:(DE-2719)1011401
|k Clinical Research Platform (CRP)
|l Clinical Research Platform (CRP)
|x 13
920 1 _ |0 I:(DE-2719)1410006
|k AG Wiltfang
|l Molecular biomarkers for predictive diagnostics of neurodegenerative diseases
|x 14
920 1 _ |0 I:(DE-2719)1011305
|k AG Schneider
|l Translational Dementia Research (Bonn)
|x 15
920 1 _ |0 I:(DE-2719)1410002
|k AG Fischer
|l Epigenetics and Systems Medicine in Neurodegenerative Diseases
|x 16
920 1 _ |0 I:(DE-2719)5000034
|k Delcode
|l Delcode
|x 17
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1011201
980 _ _ |a I:(DE-2719)1811005
980 _ _ |a I:(DE-2719)5000022
980 _ _ |a I:(DE-2719)1810002
980 _ _ |a I:(DE-2719)5000006
980 _ _ |a I:(DE-2719)1110008
980 _ _ |a I:(DE-2719)1011101
980 _ _ |a I:(DE-2719)1011102
980 _ _ |a I:(DE-2719)1340013
980 _ _ |a I:(DE-2719)1510100
980 _ _ |a I:(DE-2719)1011001
980 _ _ |a I:(DE-2719)1210000
980 _ _ |a I:(DE-2719)5000007
980 _ _ |a I:(DE-2719)1011401
980 _ _ |a I:(DE-2719)1410006
980 _ _ |a I:(DE-2719)1011305
980 _ _ |a I:(DE-2719)1410002
980 _ _ |a I:(DE-2719)5000034
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21